Pacific Biosciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PACB and other ETFs, options, and stocks.

About PACB

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific.

CEO

Christian O. Henry

CEOChristian O. Henry

Employees

575

Employees575

Headquarters

Menlo Park, California

HeadquartersMenlo Park, California

Founded

2000

Founded2000

Employees

575

Employees575

PACB Key Statistics

Market cap

705.87M

Market cap705.87M

Price-Earnings ratio

-1.03

Price-Earnings ratio-1.03

Dividend yield

—

Dividend yield—

Average volume

12.04M

Average volume12.04M

High today

$2.38

High today$2.38

Low today

$2.01

Low today$2.01

Open price

$2.05

Open price$2.05

Volume

22.75M

Volume22.75M

52 Week high

$2.72

52 Week high$2.72

52 Week low

$0.8511

52 Week low$0.8511

PACB News

TipRanks 2d

Cathie Wood Trims Stakes in 2 Big Tech Stocks, Loads Up on Deere and Pacific Biosciences

Cathie Wood’s ARK Invest ETFs (exchange-traded funds) revealed several key portfolio moves for Thursday, October 30, 2025, reflecting a pullback from big tech s...

Benzinga 2d

Cathie Wood Just Dumped $7.4 Million Worth Of Palantir And AMD Shares — Here's What Ark Is Buying Instead

On Thursday, Cathie Wood-led Ark Invest made significant trades involving Palantir Technologies Inc. (NASDAQ:PLTR), Advanced Micro Devices Inc. (NASDAQ:AMD) , P...

TipRanks 2d

Cathie Wood’s ARK Investment buys 633K shares of PacBio today

20:49 EDT Cathie Wood’s ARK Investment buys 633K shares of PacBio (PACB) today Published first on TheFly – the ultimate source for real-time, market-moving bre...

Analyst ratings

64%

of 11 ratings

Buy

36.4%

Hold

63.6%

Sell

More PACB News

Simply Wall St 3d

Does ARK’s Latest PACB Buy Reflect Renewed Confidence in Pacific Biosciences’ Genomics Leadership?

In recent days, ARK Investment Management, led by Cathie Wood, acquired 1.03 million shares of Pacific Biosciences of California, highlighting renewed instituti...

Simply Wall St 5d

Pacific Biosciences: Evaluating Valuation After Major SPRQ-Nx Platform Upgrades and Cost-Saving Advances

Pacific Biosciences of California (PACB) just unveiled major updates to its Revio and Vega platforms, introducing the SPRQ-Nx sequencing chemistry. This move is...

People also own

Based on the portfolios of people who own PACB. This list is generated using Robinhood data, and it’s not a recommendation.

CRISPR

Intellia Therapeutics